FNY Investment Advisers’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69M | Buy |
149,971
+16,380
| +12% | +$184K | 0.71% | 33 |
|
|
2025
Q1 | $761K | Buy |
133,591
+57,625
| +76% | +$328K | 0.46% | 57 |
|
|
2024
Q4 | $745K | Buy |
75,966
+42,298
| +126% | +$415K | 0.39% | 60 |
|
|
2024
Q3 | $274K | Buy |
33,668
+29,249
| +662% | +$238K | 0.13% | 145 |
|
|
2024
Q2 | $59K | Buy |
4,419
+1,619
| +58% | +$21.6K | 0.04% | 232 |
|
|
2024
Q1 | $129 | Sell |
2,800
-245
| -8% | -$11 | 0.08% | 163 |
|
|
2023
Q4 | $205K | Buy |
3,045
+2
| +0.1% | +$135 | 0.23% | 85 |
|
|
2023
Q3 | $220K | Buy |
3,043
+2
| +0.1% | +$145 | 0.13% | 99 |
|
|
2023
Q2 | $226K | Buy |
3,041
+625
| +26% | +$46.4K | 0.29% | 62 |
|
|
2023
Q1 | $128K | Sell |
2,416
-190
| -7% | -$10.1K | 0.15% | 114 |
|
|
2022
Q4 | $176K | Buy |
2,606
+789
| +43% | +$53.3K | 0.25% | 88 |
|
|
2022
Q3 | $226K | Sell |
1,817
-750
| -29% | -$93.3K | 0.16% | 89 |
|
|
2022
Q2 | $244K | Buy |
2,567
+384
| +18% | +$36.5K | 0.18% | 84 |
|
|
2022
Q1 | $351K | Buy |
2,183
+1,991
| +1,037% | +$320K | 0.33% | 62 |
|
|
2021
Q4 | $63K | Sell |
192
-1,053
| -85% | -$346K | 0.03% | 232 |
|
|
2021
Q3 | $577K | Buy |
+1,245
| New | +$577K | 0.27% | 80 |
|